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Abstract
Background: Chemokine (C-C motif) ligand 2 CCL2/MCP-1 is among the key signaling molecules of innate immunity; in
particular, it is involved in recruitment of mononuclear and other cells in response to infection, including tuberculosis (TB)
and is essential for granuloma formation.
Methodology/Principal Findings: We identified a tag SNP for the CCL2/MCP-1 gene (rs4586 C/T). In order to understand
whether this SNP may serve to evaluate the contribution of the CCL2 gene to the expression of TB disease, we further
analysed distribution of its alleles and genotypes in 301 TB cases versus 338 non-infected controls (all BCG vaccinated)
representing a high-risk pediatric population of North China. In the male TB subgroup, the C allele was identified in a higher
rate (P=0.045), and, acting dominantly, was found to be a risk factor for clinical TB (P=0.029). Homozygous TT genotype
was significantly associated with lower CSF mononuclear leukocyte (ML) counts in patients with tuberculous meningitis
(TBM) (P=0.001).
Conclusions/Significance: The present study found an association of the CCL2 tag SNP rs4586 C allele and pediatric TB
disease in males, suggesting that gender may affect the susceptibility to TB even in children. The association of
homozygous TT genotype with decreased CSF mononuclear leukocyte (ML) count not only suggests a clinical significance of
this SNP, but indicates its potential to assist in the clinical assessment of suspected TBM, where delay is critical and diagnosis
is difficult.
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Introduction
With 9 million new cases of tuberculosis (TB) worldwide in 2008
[1], the disease caused by Mycobacterium tuberculosis remains a
topmost health problem in China with over 1.3 million new cases/
year and a prevalence as high as 194/100,000 in adults and 98/
100,000 in children [1,2]. Although more than one-third of the
world’s population is potentially infected with M. tuberculosis, only
10% will develop the clinical disease over a lifetime [3]. Some
genetic factors that may account for the development of TB
disease after infection include (list not exhaustive): chemokine(C-C
motif) ligand 2 (CCL2, other designation: MCP-1), genes encoding
human leukocyte antigen type, purinergic receptor (P2X7), the
solute carrier family 11 member a1 protein (SLC11A1, formerly
known as NRAMP1), and vitamin D3 receptor [4,5,6,7,8,9,10]
although the data may vary among different ethnic groups.
CCL2 belongs to the CC chemokines characterized by two
adjacent cysteine residues close to the amino terminus. As with
many other CC chemokines, the CCL2 gene is located on
chromosome 17q11.2 in humans which has been linked to
susceptibility to tuberculosis and includes genes coding for several
chemokines where CCL2 clusters together with the nitric oxide
synthase 2A (NOS2A) and CCL3-5 genes [11,12]. The CCL2
chemokine is produced as a protein precursor containing signal
peptide of 23 amino acids and a mature peptide of 76 amino acids
[13,14]. The chemokine CCL2 is the most potent chemo-
attractant and activator for mononuclear leukocytes (MLs) and
attracts CD4 and cd T cells [15,16,17], which are central
components of the granulomatous response [18]. CCL2 can be
released directly from infected cells and by forming a chemical
gradient, escort sensitive MLs to the site of tissue injury [19].
Expression of the CCL2 gene may be found in many disorders
characterized by ML infiltration [20]. CCL2 (MCP-1) plasma
levels were significantly higher in TB adult patients of Mexican
and Han Chinese ancestry who were carriers of -2518 CCL2
genotype GG [4,7]. CCL2 binds to CCR2 receptors and was
shown to down-regulate the production of IL-12 and selectively
inhibit the induction of the Th1 immune response to Staphylococcus
aureus [21,22]. The association of -2518G allele with TB was found
in North-East Asian (north China and Korea) [4,5,7], Zambian
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[7,8] whereas lack of such an association was found for South-East
Asian (South China/Hong Kong) [18], South African Colored
and Indian [24,25] populations. In contrast, the CCL2 -2518G
allele was significantly associated with resistance to TB in
Ghanaians [26].
Childhood TB represents an important and sensitive part of the
burden of TB in the community. Compared to adults, children are
much more likely to progress to TB disease after exposure, to
develop disease more rapidly, and to develop asymptomatic extra-
pulmonary disease, disseminated (miliary) TB and tuberculous
meningitis (TBM) [27,28,29,30,31]. It has been suggested that
disseminated TB may reflect Mendelian predispositions in a
fraction of children (3–30% estimated by Bayesian statistics),
whereas adult pulmonary TB seems to reflect a more complex
genetic predisposition [32,33].
Unlike previous studies that focused on the CCL2 promoter
SNPs, we hereby report a tag SNP for the entire CCL2 gene
region. We further evaluated whether its polymorphism may serve
to elucidate the contribution of the CCL2 gene to the expression of
TB disease in a BCG-vaccinated pediatric population in North
China. We also compared the CCL2 genotypes and counts of the
MLs and polymorphonuclear (PMN) cells in the cerebrospinal
fluid (CSF) in the TBM subgroup.
Results
TB patients and non-infected controls
The case group (n=301) included 105 (34.9%) cases of active
pulmonary TB (PTB), 196 (65.1%) cases of extrapulmonary TB
(EPTB), of which was 118 (39.2%) cases of TBM. Severe
extrapulmonary tuberculosis (SevTB) identified in 172 (57.1%)
patients included those with two or more noncontiguous sites,
miliary mottling, or involvement of meningitis, pericardium,
spinal, intestinal and splenic sites with or without lung involve-
ment. The LNTB (Less severe extrapulmonary tuberculosis) group
included 24 (8%) patients with extra-pulmonary peripheral sites
restricted to lymph nodes, peripheral joints, skin or pleural
effusions without involvement of lung parenchyma. The control
group included 338 pediatric surgical patients without history of
tuberculosis. The demographic characteristics are explained in
Table 1. All study subjects were BCG vaccinated at birth. The
mean age was 5.9 years (SD, 4.8; range, 2 months–17 years) in the
TB patients group. The mean age in control group (n=338) was
5.7 years (SD, 4.1; range, 3 months–16 years). The proportions of
male were observed 61.8% in both groups. There were no
significant differences between the groups for age and sex. The
children aged less than 4 years old constituted 48.6%, 46.5%,
16.7% in PTB, SevTB and LNTB groups, respectively.
All TB cases were classified according to the diagnostic
standards of the American Thoracic Society (ATS) [34], the
Pediatric tuberculosis clinical diagnosis standard in China [35] and
WHO guidelines for disease severity classification for non-HIV
related TB [36]. Patients were included in the study if they were
positive by one or more of the following criteria: Tspot-TB test,
Acid-Fast Bacilli Stain, culture, imaging, fibreoptic bronchoscopy
(FOB) observation. The clinical records of patients were reviewed
by two pediatricians with experience of TB in children (Table 2).
Tagged-Haplotype and Linkage Disequilibrium (LD)
analysis
In the CCL2 region (chr17:29603409..29609331, from 3000 bp
59 upstream to 1000 bp 39 downstream of CCL2)the Haploblock
was constructed according to solid spine method and consisted of
four SNPs (Fig. 1). These included two SNPs of promoter region
rs1024611 (-2518A/G), rs1024610, one of exon 2 rs4586 and one
of 39UTR rs13900. Of this haplotype block, rs4586 was identified
as the tag SNP for further association analysis. As the frequency of
rs4586-C was similar to rs1024611-G, it was reasonable to expect
that the rs4586-C and rs11024611-G (-2518G) alleles would be in
perfect LD (D’=0.975 R
2=0.9, based on China Han Beijing
CHB dataset in HapMap PHASE 3: http://hapmap.ncbi.nlm.nih.
gov/).
Analysis of rs4586 variants versus disease phenotype and
gender
The genotypic and allelic frequencies of the tag SNP rs4586 of
the CCL2 were analyzed in cases and controls. The genotypes were
in HWE (Hardy-Weinberg equilibrium). The frequency of the C
allele in TB patients was 61.3%, whereas T allele frequency was
38.7%; these frequencies did not differ significantly between cases
and controls (P=0.576). Analysis of genotypic distribution using
362 x
2 test revealed no significant difference between the two
groups (P=0.664). Moreover, no significant difference in the
genotypic or allelic frequencies was found: (i) when control group
was compared to different patient subgroups stratified by
diagnosis; (ii) between PTB and EPTB subgroups (iii) between
SevTB and LNTB subgroups (Table 3).
No significant differences between the TB and control groups
were observed among male and female in genotypic frequencies
(data not shown). At the same time, it was noted that C allele was
more frequent in the male TB group (262 test, P=0.045;
OR=1.34; 95%CI 1.01–1.79). Different models of inheritance
have been tested for combined sample and sex-stratified
subsamples. In the male group, a statistical significance was
observed when the C allele was regarded as a Mendelian
dominant trait (P=0.029; OR=1.94; 95%CI 1.06–3.56). In the
female group no statistically significant differences were found
(Table 4).
In genetic studies the power of a sample set to detect an
association depends on the allele frequency and the size of its effect
(estimated as OR). For complex infectious diseases, e.g.,
tuberculosis, a mild effect of many contributing genes is more
expected; therefore we adopted the OR of 1.5. Accordingly, the
power to detect association for the minor allele T of the tag SNP in
combined sample was found to be high (95%). Indeed under the
stratification analysis, the power was lower (80% for males, 62%
for females) and this was a limitation of this study. Considering the
difficulties in recruiting children and the relatively smaller size of
the total pediatric TB population (compared to adult TB), the
design of our study may be considered appropriate. Indeed, similar
case-control studies previously described have enrolled an even
smaller number of individuals [37,38,39].
Analysis of genotype versus CSF cells counts in TBM
cases
The data on ML and PMN counts in CSF were available for 110
of 118 TBM patients. The MLs count was decreased in TT
genotype as compared with CC (P=0.044) and TC (P=0.008)
genotypes. However, no difference was observed between CC and
TC (P=0.833) in the MLs level (Fig. 2A). The effect of the CCL2
rs4586 minor allele T on the level of MLs in CSF was assessed using
both dominant (CT+TT versus CC) and recessive (TT versus
CC+CT) models. This comparison revealed a statistical significance
for recessive model for T allele (P=0.001) (Fig. 2B). The same
analysis found no significant association of either genotype/allele
and the number of PMNs in CSF (data not shown).
CCL2 and Tuberculosis
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CCL2 is essential for the recruitment of mononuclear cells and
subsequent activation of T lymphocytes, mononuclear and
polymorphonuclear cells at the site of infection [17]. Studies of
knockout mice indicated a non-redundant role of CCL2 in
modulating MLs infiltration during inflammation [40]. Its
involvement in pathogenesis of TB and granulomatous response
suggested that variation of the CCL2 gene might play a role in
conferring susceptibility to or protection from TB. However,
knockout-mice lacking CCL2 were not found to be more
susceptible to intravenous infection with M. tuberculosis [41] and
published studies on the CCL2 variation from different world
regions produced somewhat controversial conclusions [7,8,26].
In this study, knowledge-based approach and linkage analysis
using tagged-haplotype SNP were used in detecting CCL2 genetic
associations: we identified a single tag SNP for the entire CCL2
gene (rs4586) and studied its role in clinical TB in Han Chinese
pediatric population. Many studies demonstrated that haplotype
diversity can be reduced to a smaller set of ‘‘haplotype-tagging’’
SNPs (htSNPs) identifying the most common haplotypes [42,43].
Tag SNPs are useful in whole-genome SNP association studies in
which hundreds of thousands of SNPs across the entire genome
are genotyped since being representative SNPs in a genome region
with high LD, they make it possible to identify genetic variation
without genotyping every SNP in a chromosomal region of interest
[44,45]. Here, rs4586 was chosen as haplotype-tagging SNP in
order to reduce genotyping requirements by eliminating redun-
dancy in the information provided by the other SNPs in the
extended CCL2 genome region.
Our data indicated that a large proportion of cases were severe
extrapulmonary TB (SevTB). No statistically significant differences
were observed between cases of PTB and cases of SevTB. A
comparison of carriers of the rs4586 genotype CC between SevTB
and LNTB shows an increased proportion of homozygous CC
among patientswith SevTB (36.6% vs29.1%, Table 3).Although this
difference is not significant (OR 1.4, 95% CI 0.55–3.57), it provides
an interesting clue. In Chinese Han population (Hapmap-CHB)
rs4586-C and -2518-G are in perfect LD (D’=0.975 r
2=0.9).
Consequently, we speculate that the -2518 CCL2 genotype GG may
be associated with a more severe disease in a pediatric population of
HanChineseaswellasinKoreans,MexicansandPeruvians[4,5,7,8]
but not in non-Caucasian Africans, Indians and Caucasians
[24,25,26]. Our analysis has a number of limitations (small sample
size of the LNTB subgroup, difference in the mean age between
SevTB and LNTB groups, 5.75 vs 9.45 years old, respectively) hence
a larger study is needed to validate these preliminary results.
The significant associations were observed when results were
stratifiedby gender. The CC and CT genotypes and the common C
alleleweresignificantlymoreprevalentinthe male TBsubgroup.As
Table 1. Demographic characteristics of study population.
Characteristic* Number of TB patients* Control (n=338)
PTB (n=105) SevTB (n=172) LNTB (n=24) Total (n=301)
Gender
Male 68(64.8) 100(58.1) 18(75.0) 186(61.8) 209(61.8)
Age
Mean (SD), Y 5.4 (4.7) 5.8(4.7) 9.5(4.7) 5.9(4.8) 5.7(4.1)
Age group, Y
,4 51(48.6) 80(46.5) 4(16.7) 135(44.9) 131(38.7)
4–6 14(13.3) 21(12.2) 2(8.3) 37(12.3) 73(21.6)
7–9 18(17.1) 22(12.8) 5(20.8) 45(14.9) 58(17.2)
10–12 11(10.5) 33(19.2) 7(29.2) 51(16.9) 58(17.2)
13–17 11(10.5) 16(9.3) 6(25.0) 33(11.0) 18(5.3)
BCG Vaccinated Yes Yes Yes Yes Yes
*PTB, pulmonary TB; SevTB, severe extrapulmonary TB; LNTB, Less severe extrapulmonary TB; TBM, TB meningitis.
doi:10.1371/journal.pone.0014652.t001
Table 2. Diagnostic modality used for confirmation of TB.
Investigation or diagnostic procedure Number of TB patients (positive/total)*
PTB(n=105) EPTB(n=196)
PPD 100/105 169/196
Tspot-TB test 21/21 31/31
Acid-Fast Bacilli Stain 8/105 12/196
Culture 8/105 22/196
Imaging 105/105 155/196
FOB Observation 25/35 16/20
*PTB, pulmonary TB; EPTB, extrapulmonary TB; FOB, fibreoptic bronchoscopy.
doi:10.1371/journal.pone.0014652.t002
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males, we speculate that -2518-G may also be associated with TB in
Chinese male children. This hypothesis should be verified in the
further study focused specifically on the -2518 SNP. The prevalence
of TB varies on the basis of sex that may be a modifier in TB
development [46,47]. It is possible that a gender-related gene is
involved in modification of TB development, and additional
research must be performed to clarify the biological effects of
gender in TB disease. However, as the P-value was at borderline
significant level (0.045), a larger study will give better indications to
the role of this polymorphism in susceptibility to TB in males.
Unfortunately, no population data on rs4586 in relation to
clinical TB are available yet for other populations whereas CCL2
promoter SNP -2518 (rs1024611) has been extensively analyzed for
its association with clinical TB. In this view, we extended our
discussion to this latter SNP located inside the genome region under
study and found to be in LD with rs4586 in our population. We
would like to note that the association of -2518 with clinical TB
observed in some but not all populations might reflect a genuine
association owing to LD with another, putatively causal polymor-
phism in the adjacent CCL2 gene region. When comparing the
linkage plot of Chinese CHB population to the plots of the three
African populations, clear differences of LD patterns became
evident (Fig. 3).Thisis ingeneralagreementwiththe known distinct
LD patterns that exist in African and diverse non-African
populations. East Asian (Chinese and Japanese) populations had
very similar patterns of LD (for the whole haplotype block of 4
SNPs). In contrast, the association of CCL2 rs4586-C was
independent of that of -2518G in all African populations. A
moderate LD was found in the Caucasian (US residents of
European ancestry and Italians), Gujarati Indians, and Mexicans
populations (Fig. 3). Accordingly, different LD patterns between -
2518G and a causal unidentified variant adjacent to CCL2 in
different populations might explain the association with TB in some
but not all populations. To sum up, the role of the CCL2 -2518 (and
likely rs4586) in TB disease may differ for different large settings,
Africans versus East Asians versus Europeans.
It is worth mentioning that a strong association for -362C allele
(rs2857656) with protection against TB was shown in the
Ghanaian population [26], a finding in clear disagreement with
our results since this SNP is located well within our study region.
Following the above discussion on -2518 SNP in different
populations, it is not unlikely that this discrepancy may also well
be explained by variation in the LD patterns in East Asians and
Africans. The rs4586 is a useful tag-SNP in Han Chinese and
perhaps may be useful in certain other ethnic groups.
Compared to the previous studies of CCL2 and human
susceptibility to TB [4,5,7,8,25,26], this study was distinctive in
three ways. First, the targeted rs4586 was a CCL2 tag SNP thus
permitting us to assess the entire gene and surrounding regions
(+3000 bp in 59UTR and +1000 bp 39UTR). Second, we focused
on pediatric TB that is known to be clinically and pathologically
different from adult TB [33]. Third, the subjects in the study were
BCG vaccinated. The studies in Mexico and Peru [8] also focused
on BCG-vaccinated adult individuals, and they found that the
CCL2 -2518 GG and MMP-1-1607 2G/2G increased the
Figure 1. CCL2 gene structure and location of tag SNP rs4586 (T/C), a synonymous mutation at codon 35-Cys in exon 2 of CCL2.
doi:10.1371/journal.pone.0014652.g001
Table 3. Effect of CCL2 rs4586 variants on disease phenotype.
Subjects (n) * Genotype, n (%) P-value Allele P-value
CC TC TT C(%) T(%)
Control (338) 117(34.6) 170 (50.3) 51 (15.1) - 404 (59.8) 272(40.2) -
Case (301) 106 (35.2) 157 (52.2) 38 (12.6) 0.664 369(61.3) 233 (38.7) 0.576
PTB (105) 36 (34.3) 57 (54.3) 12 (11.4) 0.605 129 (61.4) 81(38.6) 0.667
EPTB (196) 70(35.7) 100 (51.0) 26 (13.3) 0.843 240 (60.6) 156 (39.4) 0.786
SevTB (172) 63(36.6) 85(49.4) 24(14.0) 0.883 211(61.3) 133(38.7) 0.627
LNTB (24) 7(29.1) 15(62.5) 2(8.0) 0.462 29(60.4) 19(39.6) 0.929
SevTB vs LNTB - - - 0.464 - - 0.902
PTB vs EPTB - - - 0.834 - - 0.843
*PTB, pulmonary tuberculosis; EPTB, extrapulmonary; SevTB, severe extrapulmonary tuberculosis; LNTB, Less severe extrapulmonary tuberculosis.
C is ancestral allele, T – derived allele when compared to the sequence of the chimpanzee.
doi:10.1371/journal.pone.0014652.t003
CCL2 and Tuberculosis
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e14652likelihood of progression to PTB. In their study all the controls
were latently infected individuals with positive PPD test and did
not develop TB disease for a period of more than 2 years after
exposure. Differences in study populations (children in this study
and adults in [8]) may explain these disparate results, particularly
with respect to the criteria for selection of controls.
In this view, it is important to mention the limitations
encountered during the design of the present study. A perfect
study of susceptibility to TB should rely on the selection of the
latently infected individuals as controls. Tuberculin Skin Test
(TST) is useful to detect infected individuals for research
purposes: Flores-Villanueva’s group found that 99% of heavily
exposed adults with a TST.15 mm are also positive to a
QuantiFeron-TB test in tube [8]. However a use of TST in
BCG-vaccinated children in a high-prevalence country, such as
China, is more than challenging. In China, immediate
chemoprophylaxis/treatment is provided to all PPD-positive
children in spite of the fact that BCG-vaccination may confound
the diagnosis of infection. Even if the truly infected controls
have been identified for the research purposes in this project,
t h e yw o u l db et r e a t e da n dt r e a t ment/chemoprophylaxis might
modify the course of infection regardless of the genetic profiles
of the study subjects. Assuming equal exposure of both groups
and since our controls remained uninfected during 2 years, we
assumed ‘‘non-infected’’ status of the controls. In this case, we
compared allele and genotype frequencies in tuberculosis
patients with those non-infected controls, allowing us to
distinguish susceptibility to infection from non-infection. An
additional limitation of our study was that we did not have some
detailed information for comparison between patients and
controls, such as children’s family history, habitat, family
income, parents’ educational level, family size. However, there
is no logical reason why these differences should cause a specific
SNP distribution to change, especially when the standard
statistical precautions of measuring HWE and LD on other
available SNP data are observed. Summing up, we believe that
our decision to use non-infected children as controls was
justifiable.
TB meningitis most commonly occurs in children aged 0 – 4
years in the world areas with a high TB prevalence, such as China,
and in adults in the areas with a low TB prevalence [48]. TB
meningitis is the most severe complication of human M. tuberculosis
infection causing death in 10% of cases with advanced disease and
severe neurologic sequelae in 80% of survivors [49]. In this
pediatric TB study, 39.2% (118/301) of cases were TBM patients,
of which 110 cases were tested for MLs counts in CSF.
Table 4. Relationship between CCL2 rs4586 polymorphisms and pediatric tuberculosis (TB), stratified by sex.
Alleles and genotypes stratified by sex TB Control x
2-value* P-value OR (95%CIl)
Male C 243 (65.3) 244 (58.4) 4.02 0.045 1.34 (1.01–1.79)
T 129(34.7) 174(41.6)
Female C 126 (54.8) 160 (62.0) 2.62 0.105 1.35 (0.94–1.93)
T 104(45.2) 98(38.0)
Male CC+TC 168(90.3) 173(82.8) 4.75 0.029 1.94 (1.06–3.56)
TT 18(9.7) 36(17.2)
Female CC+TC 95(82.7) 114(88.4) 1.64 0.200 0.63(0.30–1.29)
TT 20(17.3) 15(11.6)
*Genotype x2 value for comparison of case and control groups in the genotype and allele frequencies.
doi:10.1371/journal.pone.0014652.t004
Figure 2. Numbers of MLs (e
6/L) in CSF in different CCL2 tag SNP rs4586 genotype groups in TBM patients. (A) Comparison of homo-
and heterozygotes. (B) Testing dominant model for common allele C.
doi:10.1371/journal.pone.0014652.g002
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TBM [50]. Chemokines and their receptors play a key role in
directing the movement of MLs into the central nervous system
(CNS) in pathological states [51]. CCL2 is essential for the
recruitment of MLs hence the number of MLs in CSF may indeed
be associated with CCL2 genotype. The MCP-1–deficient mouse
study also indicated that CCL2 alone was responsible for
mononuclear cell infiltration in several inflammatory models in
vivo [41]. This prompted us to compare genotype versus
phenotype, i.e., frequencies of the genotypes and alleles of the
CCL2 tag SNP with the number of MLs (and PMNs) in the CSF.
We found that subjects homozygous for T allele had decreased
number of MLs in CSF (Fig. 2). Otherwise, the MLs level was
higher than PMN level in CSF of TBM patients (P=0.02). The
lack of association between CCL2 rs4586 genotypes and the
number of the PMNs in the CSF is readily explained by the
chemokine CCL2 more specific activity for MLs rather than
PMNs.
However the mode of action of rs4586 polymorphism on the
role of CCL2 in migration and attraction of MLs is unknown.
Synonymous variations, in particular, are assumed to be
functionally neutral both in clinical diagnosis and when
measuring evolutionary distances between species. However,
recent results suggested that silent mutations can have an effect
on subsequent protein structure and activity [52,53]. Using the
cystic fibrosis transmembrane conductance regulator (CFTR)
exon 12 splicing as a model, it was demonstrated that ,25% of
synonymous variations result in exon skipping and, hence, in an
inactive CFTR protein [52]. Furthermore, artificial combina-
tions of CFTR exon 12 synonymous and non-synonymous
substitutions were incompatible with normal RNA processing.
The CCL2 tag SNP rs4586 (Cys35Cys) targeted in this study is
located in exon 2 and may indeed affect the protein function at
transcription control by inducing aberrant skipping of the mutant
exon.
M. tuberculosis can cross the blood brain barrier (BBB) as a free
(extracellular) organism or via infected MLs/PMNs [54]. The
clinical manifestation of CNS tuberculosis is primarily a
consequence of the inflammation which develops in response to
M. tuberculosis in the CNS. Obstruction of the CSF by
inflammatory infiltrate leads to hydrocephalus, and vasculitis
contributes to infarction, causing potentially irreparable neuro-
logical damage [54]. Inhibition of this inflammation may therefore
help in preventing the sequelae of CNS TB. Corticosteroids such
as dexamethasone which suppress the production of inflammatory
cytokines and chemokines lead to better outcomes and are
recommended as adjunctive treatment for patients with TB
meningitis [55,56]. Accordingly, patients with genotype TT with
lower CSF MLs counts than genotypes CC/TC (P=0.001) may
cause less severe disease upon MLs infiltration. The TT genotype
associated with lower level of MLs infiltration appears to act as a
protection factor against stronger inflammation/more severe
disease progression. If the TT genotype is associated with more
efficient bacilli reduction in early stages of infection, then there
may be evidence of decreased caseation in lungs, and possibly a
lower incidence of inflammatory sequelae such as obstructive
hydrocephalus after TBM, in TT homozygotes. Knowing that a
patient has TT genotype may help in the correct clinical
assessment of suspected TBM, by putting less reliance on an
elevated ML count in the CSF, and greater reliance on other
indicators.
An area for future study might be to see if the number of
ventriculoperitonea (VP) shunting procedures to prevent hydro-
cephalus is decreased in patients homozygous for TT allele.
Lumbar puncture remains essential in the investigation of
suspected meningitis. In this view, although the clinical
significance of this SNP remains to be established, in practical
terms it may be useful for simple, non-invasive, genotypic
prediction of MLs low counts in CSF in different disorders. The
knowledge that a patient has TT genotype will assist the
Figure 3. Pairwise LD (r
2) plots of CCL2 variants in different populations based on preliminary data extracted from the HapMap
Phase 3 release. YRI, Yoruban in Ibadan, Nigeria; LWK, Luhya in Webuye, Kenya; MKK, Maasai in Kinyawa, Kenya; CEU, the US residents of northern
and western European ancestry; TSI, Tuscan in Italy; CHB, Han Chinese in Beijing, China; CHD, Chinese in Metropolitan Denver, Colorado; JPT,
Japanese in Tokyo, Japan; GIH, Gujarati Indians in Houston, Texas; MEX Mexican ancestry in Los Angeles, California.
doi:10.1371/journal.pone.0014652.g003
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when CSF ML count is low.
Conclusion
The present study found an association of the CCL2 tag SNP
rs4586-C allele and pediatric TB disease in males, suggesting that
the gender may affect the susceptibility to TB even in children.
This study indirectly demonstrated that CCL2 may modulate the
migration of MLs thereby influencing disease progression. The
derived T allele, acting recessively, and TT genotype are
associated with decreased level of MLs in CSF of TBM patients.
The rs4586 SNP may be useful as a simple, non-invasive,
genotypic marker able to predict low counts of MLs in CSF and
aid in appropriate clinical assessment of suspected TBM.
Materials and Methods
Ethics Statement
The clinical investigation Tag SNP Polymorphism of CCL2 and its
Role in Clinical Tuberculosis in Han Chinese Pediatric Population has been
conducted according to the principles expressed in the Declaration
of Helsinki. For research involving human participants, informed
consent has been obtained from the patients or the guardian of the
patients. The research has been approved by the Ethics
Committee of the Beijing Children’s Hospital.
Study sample
The data from 301 case patients and 338 control subjects were
included in this study. All study individuals were of the Han
Chinese ethnicity. All the cases and controls were vaccinated with
BCG at birth, which was confirmed by the presence of a scar in
the left shoulder and vaccination records in the clinical charts.
A total of 307 blood samples were obtained from pediatric
patients with TB admitted at the Beijing Children’s Hospital
(affiliated with Capital Medical University; Beijing, China)
between February 2005 and August 2010. Patients originated
from Beijing city and surrounding provinces in North China.
Children admitted consecutively to Beijing Children’s hospital
with clinical tuberculosis, a negative HIV test, were eligible to
enter the study. In this study, primary immunodeficiency (PID)
was ruled out by clinical history, examination, and the two tests for
serum immunoglobulin levels (IgG, IgM and IgA) and lymphocyte
subpopulations (CD3+ T-cells, CD56+ natural killer (NK) cells,
CD19+ B-cells and also CD4+ and CD8+ T-cells measured by
flow cytometry). Six patients were excluded due to PID. No
patients born with a height and weight bellow the 50 percentile
were included. None of patients had history of HIV infection,
malnutrition, previous history of conditions affecting immune
function, receipt of immunosuppressive therapy or other lung
disease. In addition, all cases were new TB cases: none had a
history of previous TB or had received previous treatment for TB.
Control group subjects were recruited from those admitted to
the Beijing Children’s Hospital between June 2005 and November
2007. Controls were matched with TB patients by age, sex, and
ethnicity. The control group included 338 pediatric surgical
patients without history of TB, with normal radiographic
examination findings, and with PPD skin test results ,5 mm.
The control group children were without the infection or the
history of any inflammatory, autoimmune or infectious diseases,
including TB and HIV infection. However, as we are dealing with
a pediatric group, the possibility of a control to evolve as a case in
future cannot be ruled out. All controls were therefore seen or
questioned again 2 years after their initial visit, and their non-
infection status was confirmed (with PPD skin test results ,5 mm).
In the control groups, 50 randomly selected individuals were tested
to determine whether they were infected with M. tuberculosis using
Tspot-TB test (Oxford Immunotec, Abingdon, UK), and negative
results were identified. A positive Tspot-TB test has a much higher
sensitivity than skin testing as an indicator of active and latent M.
tuberculosis infection [57,58].
DNA analysis and selection of haplotype-based tagging
SNP
Blood samples from children with TB and controls were
collected and stored at 220uC. Genomic DNA was extracted from
peripheral blood leukocytes according to standard methods.
We aimed to identify a set of SNPs that efficiently tag all of the
common allelic variants and thus likely to tag most of the unknown
common haplotypes in CCL2. The tag SNP was selected based on
ability to tag surrounding variants (chr17:29603409..29609331 ) in
the Han Chinese panel (Beijing, China) of the International
HapMap project, NCBI build B36 assembly HapMap phase III
(http://www.hapmap.org). Tagger software included in Haploview
software 4.1 [59] was used to select tag SNP. The region used in tag
SNP selection included a region from 3,000 bp 5 9upstream to 1000
bp 3 9downstream of CCL2 (Fig. 1). The synonymous TGC.TGT
variation at codon 35-Cys (rs4586) was the only tag SNP in CCL2
obtained by aggressive tagging a minor allele frequency (MAF) of
0.15, a pairwise correlation coefficient r
2 of 0.80. LD was calculated
and graphically displayed with the Haploview 4.2 software.
The rs4586 and its surrounding regions of CCL2 gene exon 2
were amplified with primers designed by Gene Tool V 1.0.0.1
(Launcher Program for Bio Tools Inc. Applications), sense primer
FWX1 59-CCCTGGTGCTGATCATCTGGA-39, and antisense
primer FWX2 59-GGTGGAGAGTGATGTTGGGGTTC-
39(Fig. 1). The cycling conditions were as follows: initial
denaturation at 94uC for 3 min; 35 cycles of 94uC for 30 s,
58.9uC for 30 s, and 72uC for 30 s; and final elongation at 72uC
for 10 min. PCR products were directly sequenced using Big Dye
Terminator 3.1 chemistry (Applied Biosystems Inc.) with the
above primers and run on a 3730xl DNA analyzer (ABI).
Determination of MLs and PMNs in CSF
The Five or more lumbar punctures were obtained from
children with tuberculous meningitis (TBM). Mononuclear
leukocytes (MLs) and polymorphonuclear (PMN) cells in CSF
were counted in a hemocytometer under a 1006 oil immersion
objective. Mononuclear leukocytes (MLs) are white blood cells
with a one-lobed nucleus; two common forms of ML are
monocytes and lymphocytes. Neutrophils together with basophils
and eosinophils form part of the polymorphonuclear cell family
(PMNs). The numbers were expressed as cells per cubic millimeter
in undiluted CSF; the final value used in our analysis was the
maximum value of all repetitions.
Genetic and statistic analysis
Statistical analysis was carried out using the Statistical Package
for Social Sciences version 13.0 (SPSS, Chicago, IL, USA).
Differences between non contiguous variables, genotype distribu-
tion and allele frequency were tested by chi-square analysis. The
student’s t-test was used to compare the numbers of the cells in the
CSF between two genotypes, and ANOVA (Games-Howell test)
was used to compare the numbers of cells in CSF for multiple
comparisons. Significant differences were indicated by a P value
,0.05. Power calculation was performed with Quanto 1.2.4
software (http://hydra.usc.edu/gxe). LDs were calculated and
graphically displayed with the Haploview 4.2 software.
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